Global Competition Review (GCR) has recommended Cooley’s Washington, DC, Brussels and London practices in the GCR 100, the annual listing and analysis of the world’s top antitrust and foreign investment practices.
The recognitions confirm Cooley’s leading role in acting for some of the world’s most innovative companies at the intersection of antitrust, screening rules, export controls, data governance restrictions and other national security considerations, as well as its teams’ success in guiding clients through investigations, reviews and enforcement actions before agencies in the European Union, UK, US and worldwide.
The inaugural edition of GCR 100: Foreign Investment Control noted that, in 2024, across Brussels, Washington, DC, and London, Cooley advised more than 1,400 clients, including more than 700 with Committee on Foreign Investment in the United States (CFIUS) or FDI-related issues, and supported transactions totaling more than US$88 billion. The publication also referenced the firm’s lengthy report of its findings based on its work on 50 non-notified CFIUS inquiries – a volume accounting for more than 10% of enforcement actions economy-wide since 2020.
The GCR 100 lauded Cooley’s antitrust and competition team in Washington, DC, the UK and Brussels based on its successful representations of, for instance, io Products in its $6.5 billion acquisition by OpenAI, Alani Nutrition’s co-founders in the $1.8 billion sale of the company, artificial intelligence (AI) and data solutions provider DataStax in its acquisition by IBM, and the Pac-12 Conference in name, image and likeness litigation, as well as global trade data analytics firm Kpler in its $240 million acquisition of Spire Global’s maritime business and UiPath, an enterprise automation and AI software company, in its acquisition of Peak, an AI-native company.
